Characteristic | N (%) or mean ± SD |
---|---|
Demographic data | |
 Age (year) | 59.5 ± 11.1 |
 Male, n (%) | 1748 (72) |
 Living in the city | 11,148 (48) |
 Hospital days | 7.2 ± 3.8 |
Medical history (n) | |
 Dyslipidemia | 931 (38) |
 Diabetes mellitus | 545 (23) |
 Hypertension | 1088 (45) |
 Myocardial disease | 160 (7) |
 Previous myocardial infarction | 24 (1) |
 Arrhythmias | 492 (20) |
 Previous stroke | 75 (3) |
 Malignancies | 6 (0.2) |
 Peripheral vascular disease | 24 (1) |
 COPD | 30 (1) |
Infarct location by ECG | |
 Inferior | 1189 (49) |
 Anterior | 1172 (48) |
 Lateral | 56 (2) |
 Killip classification | |
 Cardiogenic shock | 101 (4) |
 Noncardiogenic shock | 2316 (96) |
Laboratory data | |
 K+ (mmol/L) | 3.9 ± 0.5 |
 Creatinine (mmol/L) | 75.3 ± 29.8 |
 Na+ (mmol/L) | 139.4 ± 4.1 |
 Total cholesterol (mmol/L) | 4.5 ± 1.0 |
 HDL-C (mmol/L) | 1.1 ± 0.3 |
 LDL-C (mmol/L) | 2.8 ± 0.9 |
 Triglycerides (mmol/L) | 1.7 ± 1.2 |
 Glucose (mmol/L) | 7.1 ± 3.1 |
 ALT (unit/L) | 55.5 ± 108.3 |
 AST (unit/L) | 165.3 ± 283.1 |
 ALP (unit/L) | 72.4 ± 24.4 |
 GGT (unit/L) | 47.4 ± 69.4 |
 Cardiac troponin I (ng/mL) | 20.9 ± 60.9 |
 Creatine kinase MB (ng/ml) | 38.3 ± 75.9 |
 NT-proBNP (pg/mL) | 1829.9 ± 6019.6 |